Heterologous prime–boost strategies for COVID-19 vaccines
Abstract Background/Objective Heterologous prime–boost doses of COVID-19 vaccines
('mix-and-match'approach) are being studied to test for the effectiveness of Oxford …
('mix-and-match'approach) are being studied to test for the effectiveness of Oxford …
Emerging evidence on heterologous COVID-19 vaccine schedules—To mix or not to mix?
EPK Parker, S Desai, M Marti, KL O'Brien… - The Lancet Infectious …, 2022 - thelancet.com
As of February 2022, 27 different COVID-19 vaccines have been authorised by one or more
regulatory authorities for specific or widespread use. 1 Of these, eight vaccines have …
regulatory authorities for specific or widespread use. 1 Of these, eight vaccines have …
SARS-CoV-2 reinfection rate and estimated effectiveness of the inactivated whole virion vaccine BBV152 against reinfection among health care workers in New Delhi …
Importance A surge of COVID-19 occurred from March to June 2021, in New Delhi, India,
linked to the B. 1.617. 2 (Delta) variant of SARS-CoV-2. COVID-19 vaccines were rolled out …
linked to the B. 1.617. 2 (Delta) variant of SARS-CoV-2. COVID-19 vaccines were rolled out …
Inactivated vaccine Covaxin/BBV152: A systematic review
TI Ahmed, S Rishi, S Irshad, J Aggarwal… - Frontiers in …, 2022 - frontiersin.org
We systematically reviewed and summarized studies focusing on Bharat Biotech's Whole
Virion Inactivated Corona Virus Antigen BBV152 (Covaxin), which is India's indigenous …
Virion Inactivated Corona Virus Antigen BBV152 (Covaxin), which is India's indigenous …
[HTML][HTML] Safety and efficacy of COVID-19 prime-boost vaccinations: homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed …
SI Mallah, A Alawadhi, J Jawad, P Wasif, B Alsaffar… - Vaccine, 2023 - Elsevier
Background Booster vaccine doses against SARS-CoV-2 have been advocated to address
evidence of waning immunity, breakthrough infection, and the emergence of immune …
evidence of waning immunity, breakthrough infection, and the emergence of immune …
Inactivated COVID-19 vaccines: durability of Covaxin/BBV152 induced immunity against variants of concern
Background Covaxin/BBV152 is one of the most widely used vaccines against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and one of the few vaccines …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and one of the few vaccines …
A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects
F Dotiwala, AK Upadhyay - Frontiers in Immunology, 2022 - frontiersin.org
The world has responded to the COVID-19 pandemic with unprecedented speed and vigor
in the mass vaccination campaigns, targeted to reduce COVID-19 severity and mortality …
in the mass vaccination campaigns, targeted to reduce COVID-19 severity and mortality …
[PDF][PDF] Interim recommendations for heterologous COVID-19 vaccine schedules: interim guidance, 16 December 2021
World Health Organization - 2021 - apps.who.int
Interim recommendations for heterologous COVID-19 vaccine schedules Page 1 -1- Interim
recommendations for heterologous COVID-19 vaccine schedules Interim guidance 16 December …
recommendations for heterologous COVID-19 vaccine schedules Interim guidance 16 December …
Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin ®) in healthcare workers in Mumbai, India: A retrospective cohort analysis
A Contractor, S Shivaprakash, A Tiwari, MS Setia… - PLoS …, 2022 - journals.plos.org
Background India started its vaccination programme for Coronavirus-19 infection (COVID-
19) on 16 January 2021 with CovishieldTM (Oxford/Astra Zeneca vaccine manufactured by …
19) on 16 January 2021 with CovishieldTM (Oxford/Astra Zeneca vaccine manufactured by …
Immune responses against different variants of SARS-CoV-2 including Omicron following 6 months of administration of heterologous prime-boost COVID-19 vaccine
Comparative analysis at 1-and 6-month post-vaccination showed modest reduction in S1-
RBD IgG antibody and NAb titers against B. 1, Alpha, Beta and Delta variants in …
RBD IgG antibody and NAb titers against B. 1, Alpha, Beta and Delta variants in …